Literature DB >> 32603313

Long noncoding RNA H19X is a key mediator of TGF-β-driven fibrosis.

Elena Pachera1, Shervin Assassi2, Gloria A Salazar2, Mara Stellato1, Florian Renoux1, Adam Wunderlin1, Przemyslaw Blyszczuk1, Robert Lafyatis3, Fina Kurreeman4, Jeska de Vries-Bouwstra4, Tobias Messemaker4, Carol A Feghali-Bostwick5, Gerhard Rogler6, Wouter T van Haaften7, Gerard Dijkstra7, Fiona Oakley8, Maurizio Calcagni9, Janine Schniering1, Britta Maurer1, Jörg Hw Distler10, Gabriela Kania1, Mojca Frank-Bertoncelj1, Oliver Distler1.   

Abstract

TGF-β is a master regulator of fibrosis, driving the differentiation of fibroblasts into apoptosis-resistant myofibroblasts and sustaining the production of extracellular matrix (ECM) components. Here, we identified the nuclear long noncoding RNA (lncRNA) H19X as a master regulator of TGF-β-driven tissue fibrosis. H19X was consistently upregulated in a wide variety of human fibrotic tissues and diseases and was strongly induced by TGF-β, particularly in fibroblasts and fibroblast-related cells. Functional experiments following H19X silencing revealed that H19X was an obligatory factor for TGF-β-induced ECM synthesis as well as differentiation and survival of ECM-producing myofibroblasts. We showed that H19X regulates DDIT4L gene expression, specifically interacting with a region upstream of the DDIT4L gene and changing the chromatin accessibility of a DDIT4L enhancer. These events resulted in transcriptional repression of DDIT4L and, in turn, in increased collagen expression and fibrosis. Our results shed light on key effectors of TGF-β-induced ECM remodeling and fibrosis.

Entities:  

Keywords:  Autoimmune diseases; Autoimmunity; Cell Biology; Epigenetics; Fibrosis

Mesh:

Substances:

Year:  2020        PMID: 32603313      PMCID: PMC7456219          DOI: 10.1172/JCI135439

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  58 in total

1.  Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts. Increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts.

Authors:  A Jelaska; M Arakawa; G Broketa; J H Korn
Journal:  Arthritis Rheum       Date:  1996-08

Review 2.  Regulation of mammalian cell differentiation by long non-coding RNAs.

Authors:  Wenqian Hu; Juan R Alvarez-Dominguez; Harvey F Lodish
Journal:  EMBO Rep       Date:  2012-10-16       Impact factor: 8.807

3.  Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts.

Authors:  B Santiago; M Galindo; M Rivero; J L Pablos
Journal:  Arthritis Rheum       Date:  2001-07

4.  2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Ann Rheum Dis       Date:  2013-11       Impact factor: 19.103

5.  Plasma TGF beta in systemic sclerosis: a cross-sectional study.

Authors:  N Snowden; B Coupes; A Herrick; K Illingworth; M I Jayson; P E Brenchley
Journal:  Ann Rheum Dis       Date:  1994-11       Impact factor: 19.103

Review 6.  Transforming growth factor beta as a therapeutic target in systemic sclerosis.

Authors:  John Varga; Boris Pasche
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

7.  Transcription factor and chromatin features predict genes associated with eQTLs.

Authors:  Dennis Wang; Augusto Rendon; Lorenz Wernisch
Journal:  Nucleic Acids Res       Date:  2012-12-28       Impact factor: 16.971

8.  Multiple knockout mouse models reveal lincRNAs are required for life and brain development.

Authors:  Martin Sauvageau; Loyal A Goff; Simona Lodato; Boyan Bonev; Abigail F Groff; Chiara Gerhardinger; Diana B Sanchez-Gomez; Ezgi Hacisuleyman; Eric Li; Matthew Spence; Stephen C Liapis; William Mallard; Michael Morse; Mavis R Swerdel; Michael F D'Ecclessis; Jennifer C Moore; Venus Lai; Guochun Gong; George D Yancopoulos; David Frendewey; Manolis Kellis; Ronald P Hart; David M Valenzuela; Paola Arlotta; John L Rinn
Journal:  Elife       Date:  2013-12-31       Impact factor: 8.140

9.  GeneHancer: genome-wide integration of enhancers and target genes in GeneCards.

Authors:  Simon Fishilevich; Ron Nudel; Noa Rappaport; Rotem Hadar; Inbar Plaschkes; Tsippi Iny Stein; Naomi Rosen; Asher Kohn; Michal Twik; Marilyn Safran; Doron Lancet; Dana Cohen
Journal:  Database (Oxford)       Date:  2017-01-01       Impact factor: 3.451

10.  LncRNA MIR503HG inhibits cell migration and invasion via miR-103/OLFM4 axis in triple negative breast cancer.

Authors:  Jia Fu; Guanjun Dong; Hui Shi; Junfeng Zhang; Zhaochen Ning; Xingna Bao; Chenjie Liu; Jing Hu; Minghui Liu; Bin Xiong
Journal:  J Cell Mol Med       Date:  2019-05-06       Impact factor: 5.310

View more
  16 in total

Review 1.  Long noncoding RNAs: emerging regulators of normal and malignant hematopoiesis.

Authors:  Yi Qiu; Mingjiang Xu; Suming Huang
Journal:  Blood       Date:  2021-12-09       Impact factor: 22.113

Review 2.  Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential.

Authors:  Pei-Suen Tsou; John Varga; Steven O'Reilly
Journal:  Nat Rev Rheumatol       Date:  2021-09-03       Impact factor: 20.543

Review 3.  Novel role of long non-coding RNAs in autoimmune cutaneous disease.

Authors:  Anastasiya Muntyanu; Michelle Le; Zainab Ridha; Elizabeth O'Brien; Ivan V Litvinov; Philippe Lefrançois; Elena Netchiporouk
Journal:  J Cell Commun Signal       Date:  2021-08-03       Impact factor: 5.782

4.  LncRNA MIR503HG Promotes High-Glucose-Induced Proximal Tubular Cell Apoptosis by Targeting miR-503-5p/Bcl-2 Pathway.

Authors:  Xu Cao; Qiu-Ling Fan
Journal:  Diabetes Metab Syndr Obes       Date:  2020-11-20       Impact factor: 3.168

5.  Characterizing DNA methylation signatures and their potential functional roles in Merkel cell carcinoma.

Authors:  Hemant Gujar; Arjun Mehta; Hong-Tao Li; Yvonne C Tsai; Xiangning Qiu; Daniel J Weisenberger; Miriam Galvonas Jasiulionis; Gino K In; Gangning Liang
Journal:  Genome Med       Date:  2021-08-16       Impact factor: 11.117

6.  Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis.

Authors:  Nikolaos I Vlachogiannis; Simon Tual-Chalot; Eleftherios Zormpas; Francesca Bonini; Panagiotis A Ntouros; Maria Pappa; Vasiliki-Kalliopi Bournia; Maria G Tektonidou; Vassilis L Souliotis; Clio P Mavragani; Kimon Stamatelopoulos; Aikaterini Gatsiou; Petros P Sfikakis; Konstantinos Stellos
Journal:  J Autoimmun       Date:  2021-11-29       Impact factor: 7.094

7.  LncRNA-COX2 inhibits Fibroblast Activation and Epidural Fibrosis by Targeting EGR1.

Authors:  Lei Yang; Shengnai Zheng; Dawei Ge; Mingjie Xia; Haijun Li; Jian Tang
Journal:  Int J Biol Sci       Date:  2022-01-16       Impact factor: 6.580

Review 8.  Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis.

Authors:  Jiangfan Yu; Rui Tang; Ke Ding
Journal:  Int J Gen Med       Date:  2022-03-19

9.  Prediction of a Competing Endogenous RNA Co-expression Network by Comprehensive Methods in Systemic Sclerosis-Related Interstitial Lung Disease.

Authors:  Yue-Mei Yan; Ji-Na Zheng; Li-Wei Wu; Qian-Wen Rao; Qiao-Rong Yang; Di Gao; Qiang Wang
Journal:  Front Genet       Date:  2021-07-05       Impact factor: 4.599

Review 10.  Non-Coding RNA in Systemic Sclerosis: A Valuable Tool for Translational and Personalized Medicine.

Authors:  Marta Rusek; Dorota Krasowska
Journal:  Genes (Basel)       Date:  2021-08-24       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.